Acute lymphoblastic leukaemia
- PMID: 18358930
- DOI: 10.1016/S0140-6736(08)60457-2
Acute lymphoblastic leukaemia
Abstract
Acute lymphoblastic leukaemia, a malignant disorder of lymphoid progenitor cells, affects both children and adults, with peak prevalence between the ages of 2 and 5 years. Steady progress in development of effective treatments has led to a cure rate of more than 80% in children, creating opportunities for innovative approaches that would preserve past gains in leukaemia-free survival while reducing the toxic side-effects of current intensive regimens. Advances in our understanding of the pathobiology of acute lymphoblastic leukaemia, fuelled by emerging molecular technologies, suggest that drugs specifically targeting the genetic defects of leukaemic cells could revolutionise management of this disease. Meanwhile, studies are underway to ascertain the precise events that take place in the genesis of acute lymphoblastic leukaemia, to enhance the clinical application of known risk factors and antileukaemic agents, and to identify treatment regimens that might boost the generally low cure rates in adults and subgroups of children with high-risk leukaemia.
Similar articles
-
Acute lymphoblastic leukaemia.Lancet. 2013 Jun 1;381(9881):1943-55. doi: 10.1016/S0140-6736(12)62187-4. Epub 2013 Mar 22. Lancet. 2013. PMID: 23523389 Free PMC article. Review.
-
[A brief history of treatments for childhood acute lymphoblastic leukaemia].Bull Acad Natl Med. 2009 Oct;193(7):1495-9; discussion 1499-500. Bull Acad Natl Med. 2009. PMID: 20669630 French.
-
Recent advances in the treatment and understanding of childhood acute lymphoblastic leukaemia.Cancer Treat Rev. 2003 Feb;29(1):31-44. doi: 10.1016/s0305-7372(02)00106-8. Cancer Treat Rev. 2003. PMID: 12633578 Review.
-
New therapeutic strategies for the treatment of acute lymphoblastic leukaemia.Nat Rev Drug Discov. 2007 Feb;6(2):149-65. doi: 10.1038/nrd2240. Nat Rev Drug Discov. 2007. PMID: 17268486 Review.
-
Treatment of acute lymphoblastic leukaemia in countries with limited resources; lessons from use of a single protocol in India over a twenty year period [corrected].Eur J Cancer. 2005 Jul;41(11):1570-83. doi: 10.1016/j.ejca.2004.11.004. Epub 2005 Jan 5. Eur J Cancer. 2005. PMID: 16026693 Review.
Cited by
-
Acute lymphoblastic leukaemia.Lancet. 2013 Jun 1;381(9881):1943-55. doi: 10.1016/S0140-6736(12)62187-4. Epub 2013 Mar 22. Lancet. 2013. PMID: 23523389 Free PMC article. Review.
-
Cell death sensitization of leukemia cells by opioid receptor activation.Oncotarget. 2013 May;4(5):677-90. doi: 10.18632/oncotarget.952. Oncotarget. 2013. PMID: 23633472 Free PMC article.
-
Loss of MXD3 induces apoptosis of Reh human precursor B acute lymphoblastic leukemia cells.Blood Cells Mol Dis. 2015 Apr;54(4):329-35. doi: 10.1016/j.bcmd.2014.12.002. Epub 2014 Dec 20. Blood Cells Mol Dis. 2015. PMID: 25554682 Free PMC article.
-
Obesity in patients with acute lymphoblastic leukemia in childhood.Ital J Pediatr. 2012 Jan 27;38:4. doi: 10.1186/1824-7288-38-4. Ital J Pediatr. 2012. PMID: 22284631 Free PMC article. Review.
-
Hydrogen sulfide-releasing aspirin inhibits the growth of leukemic Jurkat cells and modulates β-catenin expression.Leuk Res. 2013 Oct;37(10):1302-8. doi: 10.1016/j.leukres.2013.07.004. Epub 2013 Jul 26. Leuk Res. 2013. PMID: 23896061 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous